small molecule

ARAKODA

TAFENOQUINE SUCCINATE

Loss of exclusivityDecember 2035latest FDA-listed patent expiry

Company60 DEGREES PHARMACEUTICALS, LLC →See this company's full patent-cliff portfolio

Drug detail

Brand name	ARAKODA
Active ingredient	TAFENOQUINE SUCCINATE
Strength	EQ 100MG BASE
Dosage form	TABLET
Route	ORAL
Modality	Small molecule
FDA approval	August 2018
Marketing status	RX

Listed patents

Patent	Expires	Type
10342791	December 2035	use U-2582
11744828	December 2035	use U-2582
10888558	December 2035	use U-2582
12616689	December 2035	use U-2582

Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.